相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile
Aoibhinn McDonnell et al.
BRAIN (2016)
From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial
John McNeish et al.
CELL STEM CELL (2015)
Erythromelalgia Mutation Q875E Stabilizes the Activated State of Sodium Channel Nav1.7
Theresa Stadler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Novel SCN9A Mutations Underlying Extreme Pain Phenotypes: Unexpected Electrophysiological and Clinical Phenotype Correlations
Edward C. Emery et al.
JOURNAL OF NEUROSCIENCE (2015)
Specific changes in conduction velocity recovery cycles of single nociceptors in a patient with erythromelalgia with the I848T gain-of-function mutation of Nav1.7
Barbara Namer et al.
PAIN (2015)
Inherited Pain SODIUM CHANNEL NAV1.7 A1632T MUTATION CAUSES ERYTHROMELALGIA DUE TO A SHIFT OF FAST INACTIVATION
Mirjam Eberhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H
Dmytro V. Vasylyev et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
Painful and painless channelopathies
David L. H. Bennett et al.
LANCET NEUROLOGY (2014)
Characterizing Human Stem Cell-derived Sensory Neurons at the Single-cell Level Reveals Their Ion Channel Expression and Utility in Pain Research
Gareth T. Young et al.
MOLECULAR THERAPY (2014)
Tetraspanin proteins promote multiple cancer stages
Martin E. Hemler
NATURE REVIEWS CANCER (2014)
A new Nav1.7 mutation in an erythromelalgia patient
Mark Estacion et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
A Novel SCN9A Mutation Responsible for Primary Erythromelalgia and Is Resistant to the Treatment of Sodium Channel Blockers
Min-Tzu Wu et al.
PLOS ONE (2013)
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2012)
Treatment of Na(v)1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
Yigal Paul Goldberg et al.
PAIN (2012)
Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Nav1.7 mutant channel
Yang Yang et al.
NATURE COMMUNICATIONS (2012)
Nav1.7 mutations associated with paroxysmal extreme pain disorder, but not erythromelalgia, enhance Navβ4 peptide-mediated resurgent sodium currents
Jonathan W. Theile et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
A Novel Nav1.7 Mutation Producing Carbamazepine-Responsive Erythromelalgia
Tanya Z. Fischer et al.
ANNALS OF NEUROLOGY (2009)
Early- and late-onset inherited erythromelalgia: genotypephenotype correlation
Chongyang Han et al.
BRAIN (2009)
Transfection of rat or mouse neurons by biolistics or electroporation
Sulayman D. Dib-Hajj et al.
NATURE PROTOCOLS (2009)
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders
Joost P. H. Drenth et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel α subunit Nav1.7
JJ Michiels et al.
ARCHIVES OF NEUROLOGY (2005)
Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons
SD Dib-Hajj et al.
BRAIN (2005)
Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy
TR Cummins et al.
JOURNAL OF NEUROSCIENCE (2004)
Pathological C-fibres in patients with a chronic painful condition
K Orstavik et al.
BRAIN (2003)